company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4227000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4227000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,101000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,341000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1263000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2522000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2522000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11407000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14350000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2943000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2943000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-60000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,378000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,318000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,318000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,106000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,845000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,29141000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,29141000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,194000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-117000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,538000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-25152000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4604000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4604000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18210000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10449000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7761000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7761000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-42000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,401000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,359000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,359000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2807000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,37000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5833000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5833000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,189000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,151000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,375000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5107000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5107000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24347000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15612000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8735000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8735000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-43000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13853000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13810000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13810000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,12000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:02:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6556000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6556000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,36000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-151000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1439000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-48000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5280000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5280000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8809000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15231000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6422000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6422000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-14000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,61000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1191000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5076000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5076000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,30000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,241000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,182000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,451000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4172000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4172000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6658000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11139000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4478000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4478000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-10000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-10000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,297000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5300000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5300000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,30000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-136000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,408000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-340000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5338000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5338000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8252000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12067000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3815000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3815000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-9000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,106000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,97000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,97000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1428000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6218000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6218000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-79000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,413000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,654000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5230000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5230000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4050000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,9000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7918000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3877000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3877000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-9000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,31000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,22000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,22000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:17:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1331000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5419000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5419000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-77000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,434000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,262000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4800000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4800000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5788000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,94000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14087000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8393000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8393000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-10000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,67000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,57000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,57000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3650000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2402000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2402000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,88000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-5000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,532000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3519000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5306000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5306000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5771000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,149000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2878000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2744000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2744000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-9000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6869000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6860000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6860000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1192000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6810000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6810000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,21000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,28000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,299000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,165000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6297000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6297000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-41119000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6065000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-35054000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-35054000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,28000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,32000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,91237000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,91297000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,91233000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,49883000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6123000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6123000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,145000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,582000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1189000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6585000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6585000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-54867000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,8000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21773000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-33086000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-33086000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,208000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,208000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,208000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q1,2013-01-01,2013-03-31,2013-05-07 16:17:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-39463000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9081000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9081000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,328000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1077000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2232000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5444000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5444000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-63000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-107165000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-8000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8620000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-98616000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-98616000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,109871000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,109871000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,109871000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5811000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10695000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10695000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,40000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,465000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1868000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1153000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9475000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9475000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-427000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24724000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,12000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21196000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3943000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3943000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,974000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,974000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,974000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12444000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12049000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12049000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,39000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,590000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2174000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1019000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10265000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10265000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-128000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24829000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,34498000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9541000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9541000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,629000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,629000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,629000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-96000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17828000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17828000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,43000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,311000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3162000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,130000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14182000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14182000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-150921000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,51815000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-99112000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-99112000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,198042000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,198042000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,198042000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,0.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:17:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,84748000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21495000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21495000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,42000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-322000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4331000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,477000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16967000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16967000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-137718000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,70208000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-67510000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-67510000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1720000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1720000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1720000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-82757000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24786000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24786000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,60000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,356000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3901000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2985000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17484000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17484000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-80000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18572000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,57525000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,38873000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,38873000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1282000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1282000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1282000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22671000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28366000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28366000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,61000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,139000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4645000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5720000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17801000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17801000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-94000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28150000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,68720000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,40476000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,40476000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2807000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2807000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2807000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,25485000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40375000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40375000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,122000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-289000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14528000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,668000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25346000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25346000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-988000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49646000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,89107000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,38473000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,38473000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1439000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1439000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1439000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:22:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14570000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39378000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39378000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,280000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-826000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7499000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2551000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29874000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29874000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-674000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-75609000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,120347000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,44064000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,44064000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2599000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2599000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2599000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16788000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38906000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38906000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,117000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-787000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9265000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1542000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31853000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31853000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-186000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-90671000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,99165000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8308000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8308000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1132000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1132000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1132000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22413000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45784000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45784000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,128000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-158000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8655000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2437000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34722000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34722000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-293000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-53560000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,110578000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,56725000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,56725000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-292000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9377000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,247000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9332000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9332000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,31339000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,415000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49762000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49762000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,138000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-234000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11960000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3314000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-41212000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-41212000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-207000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-240566000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,72077000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-168696000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-168696000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,282991000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,282991000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,282991000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:26:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,73082000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-71322000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-71322000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,204000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,257000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13883000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,233000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-56745000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-56745000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-580000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8000000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-86063000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,87183000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7460000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7460000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6438000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,14320000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,20758000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,20758000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-43446000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-71613000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-71613000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,241000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,737000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14009000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7364000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-49262000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-49262000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-470000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-266239000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,111801000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-154908000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-154908000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,226077000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,226077000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,226077000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21905000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-78696000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-78696000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,260000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,314000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14822000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2111000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-61189000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-61189000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-249000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-90487000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,159876000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,69140000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,69140000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3390000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,596000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3986000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3986000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11941000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-365000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-87843000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-87843000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,270000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,256000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15571000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1085000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-70661000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-70661000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-485000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-140746000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,194166000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,52935000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,52935000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11490000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11490000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11490000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q1,2017-01-01,2017-03-31,2017-05-09 16:26:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6237000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-67441000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-67441000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,307000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,185000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18244000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10095000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-58800000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-58800000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-264000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-109261000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,147824000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,38299000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,38299000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7010000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7010000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7010000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13494000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65248000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65248000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,327000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,529000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19698000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13707000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-58401000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-58401000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-56000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-103833000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,123221000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19332000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19332000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7897000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7897000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7897000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-31173000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-68871000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-68871000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,332000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,216000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22023000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,16405000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29895000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29895000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-124978000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,106892000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18093000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18093000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4791000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4791000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4791000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-43192000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1367000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54296000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54296000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,392000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,194000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20451000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11977000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-45236000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-45236000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-448000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26345000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,116411000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,89618000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,89618000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2880000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2880000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2880000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 18:01:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,47260000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-63266000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-63266000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,342000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,265000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20822000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,924000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-40913000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-40875000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-115000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-62567000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,58740000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3942000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3942000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2953000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2953000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2953000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-41860000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-62138000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-62138000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,382000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,226000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,21884000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2603000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-42249000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-42280000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1015000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9617000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,5000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,42411000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,31784000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,31784000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,211000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,211000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,211000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10285000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65492000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65492000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,413000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,213000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20335000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5459000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-39072000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-39079000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-570000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-232534000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,39000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,44116000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-188949000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-188949000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,300603000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,300603000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,300603000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,72573000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1261000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-85304000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-85304000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,415000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-636000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20945000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,405000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-64175000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-64175000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-822000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-73945000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,97525000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,22758000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,22758000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4176000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4176000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4176000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 18:00:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-37240000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54941000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54941000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,326000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-659000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19601000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2763000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-38436000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-38397000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-102732000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,113379000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10627000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10627000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4646000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4646000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4646000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-23125000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41978000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41978000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,282000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-657000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,24306000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-773000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18820000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18851000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-80000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-84182000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,94185000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9923000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9923000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,319967000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,319967000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,319967000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,311042000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53036000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53036000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,266000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-184000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20294000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2961000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29699000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29707000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-207000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-317775000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,108838000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-209144000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-209144000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,43058000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,43058000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,43058000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-195796000.0
ACADIA Pharmaceuticals Inc,ACAD,,0001070494,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1597000.0
